Corcept Therapeutics (CORT) Deferred Taxes (2017 - 2026)
Corcept Therapeutics (CORT) reported Deferred Taxes of -$13.1 million for Q1 2026, up 4.34% on a YoY basis from -$12.6 million in Q1 2025, and up 13.65% sequentially from -$15.2 million in Q4 2025.
Corcept Therapeutics (CORT) Deferred Taxes (2017 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 10 years of Deferred Taxes data on file, last reported at -$13.1 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 4.34% year-over-year to -$13.1 million; the trailing twelve-month figure through Mar 2026 stood at -$36.9 million (up 20.95% YoY), and the FY2025 full-year result was -$37.5 million, up 6.6% from the prior year.
- Deferred Taxes improved to -$13.1 million in Q1 2026, from -$15.2 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $9.1 million in Q3 2025 to a low of -$17.8 million in Q2 2025.
- A 5-year average of -$9.1 million and a median of -$9.9 million in 2022 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes sank 678.8% in 2022 and jumped 159.93% in 2025, its largest moves.
- Tracing CORT's Deferred Taxes over 5 years: stood at -$4.5 million in 2022, then advanced by 17.8% to -$3.7 million in 2023, then fell by 5.07% to -$3.9 million in 2024, then plunged by 293.52% to -$15.2 million in 2025, then advanced by 13.65% to -$13.1 million in 2026.
- Business Quant data shows CORT's Deferred Taxes at -$13.1 million in Q1 2026, -$15.2 million in Q4 2025, and $9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn | -13.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -15.18 Mn |
| Sep 30, 2025 | 9.11 Mn |
| Jun 30, 2025 | -17.76 Mn |
| Mar 31, 2025 | -13.71 Mn |
| Dec 31, 2024 | -3.86 Mn |
| Sep 30, 2024 | -15.21 Mn |
| Jun 30, 2024 | -13.96 Mn |
| Mar 31, 2024 | -7.16 Mn |
| Dec 31, 2023 | -3.67 Mn |
| Sep 30, 2023 | -8.86 Mn |
| Jun 30, 2023 | -10.24 Mn |
| Mar 31, 2023 | -6.73 Mn |
| Dec 31, 2022 | -4.47 Mn |
| Sep 30, 2022 | -8.87 Mn |
| Jun 30, 2022 | -10.63 Mn |
| Mar 31, 2022 | -9.94 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 5.87 Mn |